Article
Comparative in vitro activities of eravacycline and tigecycline against carbapenem-resistant Acinetobacter baumannii: Insights from whole genome sequencing analysis.
Journal of global antimicrobial resistance - 1 Sept 2025
Zhong Yang, Teo Jocelyn Qi Min, Chang Hong Yi, Yeo Jiahao, Thong Shuhua, Tan Sihui, Yusoff Nurhayati Binte Monhamed, Lim Tze Peng, Kwa Andrea Lay Hoon
Abstract excerpt
OBJECTIVES: Eravacycline (ERV), a novel tetracycline-class antibiotic, has demonstrated efficacy against carbapenem-resistant Acinetobacter baumannii (CRAB) in Europe and the United States but has not been evaluated in Singapore. The objectives of this study are to evaluate the activity of ERV against CRAB clinical isolates from Singapore and to investigate the genetic profiles of these isolates, exploring novel...
Topics
- Humans
- Acinetobacter baumannii
- Acinetobacter Infections
- Carbapenems
- Drug Resistance, Bacterial
- Drug Resistance, Multiple
- Genome, Bacterial
- Mutation
- Phylogeny
